Antioxidant activity of mangafodipir is not a new finding [4] (multiple letters)

Journal of Hepatology

Volumn 40, Issue 5, 2004, Pages 872-873

  Karlsson, Jan Olof G ^a   Batteux, Frédéric ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Hopital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; MANGAFODIPIR; MANGANESE DERIVATIVE; MANGANESE DIPYRIDOXYL ETHYLDIAMINE; PARACETAMOL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME ACTIVITY; HEART CONTRACTION; HEART INFARCTION SIZE; HEART PROTECTION; HEMODYNAMIC MONITORING; HUMAN; LETTER; LIVER FAILURE; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL; REPERFUSION;

EID: 1942535053     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.02.022     Document Type: Letter

References (4)

1. S Bedda A Laurent F Conti C Chéreaux A Tran N Tran-Van Mangafodipir prevents liver injury induced by acetaminophen in mouse J Hepatol 39 2003 765 772
2. H Brurok J.H Ardenkjær-Larsen G Hansson S Skarra K Berg J.O.G Karlsson Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties Biochem Biophys Res Commun 254 1999 768 772
3. J.O.G Karlsson H Brurok M Eriksen R Towart K.G Toft O Moen Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium Acta Radiol 42 2001 540 547
4. K.G Toft S.O Hustvedt D Grant I Martinsen P.B Gordon G.A Friisk Metabolism and pharmacokinetics of MnDPDP in man Acta Radiol 38 1997 677 689